DNMT3A c.2043C>G ;(p.I681M)

Variant ID: 2-25464470-G-C

NM_022552.4(DNMT3A):c.2043C>G;(p.I681M)

This variant was identified in 6 publications

View GRCh38 version.




Publications:


Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022

Variant appearance in text: DNMT3A: 2043C>G; I681M
PubMed Link: 36238300
Variant Present in the following documents:
  • Table_1.xlsx, sheet 4
View BVdb publication page



EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: DNMT3A: 2043C>G; I681M
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: DNMT3A: 2043C>G; I681M
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.

Clinical And Translational Medicine
Li, Ziyang Z; Huang, Wensou W; Yin, Jiani C JC; Na, Chenglong C; Wu, Xue X; Shao, Yang Y; Ding, Huaxin H; Li, Jinming J
Publication Date: 2020-11

Variant appearance in text: rs747472028
PubMed Link: 33252848
Variant Present in the following documents:
  • CTM2-10-e222-s003.xlsx, sheet 1
View BVdb publication page



Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphoma.

Blood Cancer Journal
Yabe, Mariko M; Gao, Qi Q; Ozkaya, Neval N; Huet, Sarah S; Lewis, Natasha N; Pichardo, Janine D JD; Moskowitz, Alison J AJ; Horwitz, Steven M SM; Dogan, Ahmet A; Roshal, Mikhail M
Publication Date: 2020-03-06

Variant appearance in text: DNMT3A: I681M
PubMed Link: 32144240
Variant Present in the following documents:
  • 41408_2020_301_MOESM1_ESM.pdf
View BVdb publication page



Incidence and prognostic impact of DNMT3A mutations in Korean normal karyotype acute myeloid leukemia patients.

Biomed Research International
Park, Sang Hyuk SH; Choi, Jae-Cheol JC; Kim, Shine Young SY; Yi, Jongyoun J; Oh, Seung Hwan SH; Kim, In-Suk IS; Kim, Hyung-Hoi HH; Chang, Chulhun Ludgerus CL; Lee, Eun Yup EY; Song, Moo-Kon MK; Shin, Ho-Jin HJ; Chung, Joo Seop JS
Publication Date: 2015

Variant appearance in text: DNMT3A: 2043C>G
PubMed Link: 25650308
Variant Present in the following documents:
  • Main text
  • BMRI2015-723682.pdf
View BVdb publication page